ALG-125755
ALG-125755-501
Phase 1 small_molecule terminated
Quick answer
ALG-125755 for Chronic Hepatitis B is a Phase 1 program (small_molecule) at Aligos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aligos Therapeutics
- Indication
- Chronic Hepatitis B
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated